{"id":"W4293553347","doi":"10.14740/jh1035","title":"Durable Remission in Hodgkin Lymphoma Treated With One Cycle of Bleomycin, Vinblastine, Dacarbazine and Two Doses of Nivolumab and Brentuximab Vedotin","year":2022,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dacarbazine; Brentuximab vedotin; Vinblastine; ABVD; Nivolumab; Bleomycin; Internal medicine; Cyclophosphamide; Procarbazine; Lymphoma; Oncology; Vincristine; Chemotherapy; Radiology; Hodgkin lymphoma; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000199835,0.0002299873,0.0004005276,0.0002232954,0.000477089,0.0002562518,0.0002727898,0.0007515341,0.0007409129],"category_scores_gemma":[0.0005979132,0.0001551736,0.0003125872,0.0002192047,0.0002310877,0.0002327782,0.0002358681,0.001235406,0.0001887371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000485734,"about_ca_system_score_gemma":0.0003355188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001535528,"about_ca_topic_score_gemma":0.004006998,"domain_scores_codex":[0.9998821,0.0000216377,0.00001273182,0.00002158774,0.00001485128,0.0000469791],"domain_scores_gemma":[0.9997814,0.00004600561,0.00002591642,0.00001732536,0.00001016533,0.0001192151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.01330832,0.004077893,0.09915441,0.0006867722,0.0004067218,0.5808455,0.001377897,0.00257416,0.04481355,0.001428013,0.008427283,0.2428995],"study_design_scores_gemma":[0.005186713,0.02939064,0.2966702,0.0002475199,0.0006712637,0.6150562,0.0004210864,0.005913013,0.01305479,0.001388384,0.0319235,0.00007669153],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984803,0.006510528,0.001021168,0.002716493,0.0002083867,0.0001143139,0.0001728742,0.0000791925,0.004374032],"genre_scores_gemma":[0.9961618,0.00110414,0.0002436586,0.0009147638,0.000138029,0.00001789516,0.0002624206,0.000006705837,0.001150593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001535528,"threshold_uncertainty_score":0.003524244,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008509687977466355,"score_gpt":0.2426546961957102,"score_spread":0.2341450082182438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}